SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Clinical trial NCT06846424 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06846424
Sponsor: Shanghai Gynecologic Oncology Group
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Carcinoma Peritoneal Carcinoma

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.